Cargando…
Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins
Mitoxantrone is a potent antitumor drug, widely used in the treatment of various cancers. In the present study, we have investigated and compared the affinity of anticancer drug, mitoxantrone, to EDTA-soluble chromatin (SE-chromatin), DNA and histones employing UV/Vis, fluorescence, CD spectroscopy,...
Autores principales: | Hajihassan, Zahra, Rabbani-Chadegani, Azra |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660295/ https://www.ncbi.nlm.nih.gov/pubmed/19284573 http://dx.doi.org/10.1186/1423-0127-16-31 |
Ejemplares similares
-
The effect of mitoxantrone as an anticancer drug on hepatocytes nuclei and chromatin: Selective release of histone proteins
por: Hajihassan, Zahra, et al.
Publicado: (2011) -
Engineering a variant of IL-17RA with high binding affinity to IL-17A for optimized immunotherapy
por: Armaghan, Fatemeh, et al.
Publicado: (2021) -
Engineering a CEACAM1 Variant with the Increased Binding Affinity to TIM-3 Receptor
por: Hajihassan, Zahra, et al.
Publicado: (2023) -
Chromatin as a Target for the DNA-Binding Anticancer Drugs
por: Majumder, Parijat, et al.
Publicado: (2007) -
Binding mechanism of anti-cancer chemotherapeutic drug mitoxantrone to DNA characterized by magnetic tweezers
por: Kreft, Dennis, et al.
Publicado: (2018)